Labelling for pharmaceutical and medical devices has been exploring opportunities to improve alignment globally while delivering local regulatory requirements while addressing initiatives such as SCA, IDMP, Project Orbis, elabelling, ePIL, IVD & devices and others. Many organizations have applied digital initiatives in the labelling process, but success can come with risk to compliance in operations, delays in technology deployment, and cost over runs. Frequently organizations aspire to create impact but settle on efficiency outcomes falling short on longer term goals of improving the business effectiveness. A truly effective plan to needs to consider organizational and technical readiness and the mindset of how technology can be applied to deliver desired outcomes. In the course of this presentation attendees will gain insights on defining, managing the change, and achieving effective labelling operations that extends beyond incremental impact in efficiency.
Learning Objectives:
Defining and managing the change
Achieving effective labelling operations that extends beyond incremental impact in efficiency